Boryung Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boryung Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
KolmarBNH Co Ltd
sales of 419.81 billion Korean Won [US$372.37 million]
of which 64%
Chongkundang Holdings Corp
(450.74 billion Korean Won [US$399.80 million]
of which 97%
was Medicine), and
(417.97 billion Korean Won [US$370.74 million]
During the year ended December of 2017, sales at
Boryung Pharmaceutical Company Limited were 422.72 billion Korean Won (US$374.95 million).
increase of 3.3%
versus 2016, when the company's sales were 409.14 billion Korean Won.
This was the fifth consecutive year of sales increases at Boryung Pharmaceutical Company Limited
(and since 2012, sales have increased a total of 35%).